Bioorganic & Medicinal Chemistry
Design, synthesis, and biological evaluation of quinazoline–benzohydrazide and quinazoline–benzothiazole hybrids uncovering a dual EGFR/VEGFR-2 inhibitor with pronounced cytotoxic activity against triple-negative breast Cancer
Publication date: Available online 6 December 2025Source: Bioorganic & Medicinal ChemistryAuthor(s): Noura F.M. El Hamaky, Abdelrahman Hamdi, Waleed A. Bayoumi, Abdullah A. Elgazar, Magda N.A. Nasr